Interventional Pharmacology

Monday, May 20, 2019: 3:00 PM-4:00 PM
Mont Royal (The Cosmopolitan of Las Vegas)
Moderators:
Issam D. Moussa, M.D., FSCAI and Jay S. Giri, M.D.
Panelists:
Neal S. Kleiman, M.D., MSCAI , Wayne B. Batchelor, M.D., FSCAI , Ricardo A. Costa, M.D., Ph.D. , Abdullah Shehab, M.D., Ph.D., FSCAI and Hui Chen, M.D.
3:00 PM
Abbreviated DAPT: Current Practice and Contemporary Trials
Ajay J. Kirtane, M.D., FSCAI, Columbia University Medical Center
3:10 PM
What Is the Role for Cangrelor or GP IIB/IIIA Inhibitors in Today’s Practice?
Prospero B. Gogo, M.D., FSCAI, University of Vermont Medical Center
3:20 PM
How to Switch to DAPT in 2019: Current Evidence and Recommendations
Kyung Woo Park, M.D., Ph.D., Seoul National University Hospital
3:30 PM
Triple Therapy in 2019: Can I, When Do I, and Which Agent Do I Drop?
Amit N. Vora, M.D., Pinnacle Health Cardiovascular Institute
3:40 PM
Antiplatelet and Genetic Testing in 2019: Does a Need Exist?
Rick Stouffer, M.D., UNC McAllister Heart Institute
3:50 PM
Discussion
See more of: Coronary
<< Previous Session | Next Session >>